{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:21:46Z","timestamp":1789986106305,"version":"4.0.1"},"reference-count":138,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1213\/ane.0000000000000063","type":"journal-article","created":{"date-parts":[[2014,1,21]],"date-time":"2014-01-21T03:12:44Z","timestamp":1390273964000},"page":"397-406","source":"Crossref","is-referenced-by-count":44,"title":["DNA Testing for Malignant Hyperthermia"],"prefix":"10.1213","volume":"118","author":[{"given":"Kathryn M.","family":"Stowell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-22-20210902","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1007\/s00101-002-0390-x","article-title":"Current aspects of the diagnosis of malignant hyperthermia.","volume":"51","author":"Ruffert","year":"2002","journal-title":"Anaesthesist"},{"key":"R2-22-20210902","first-page":"51","article-title":"Malignant hyperpyrexia.","volume":"1","author":"Denborough","year":"1975","journal-title":"Compr Ther"},{"key":"R3-22-20210902","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0140-6736(60)92690-8","article-title":"Anaesthetic deaths in a family.","volume":"2","author":"Denborough","year":"1960","journal-title":"Lancet"},{"key":"R5-22-20210902","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1213\/00000539-198910000-00015","article-title":"Standardization of the caffeine halothane muscle contracture test. North American Malignant Hyperthermia Group.","volume":"69","author":"Larach","year":"1989","journal-title":"Anesth Analg"},{"key":"R6-22-20210902","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00000542-199803000-00006","article-title":"The sensitivity and specificity of the caffeine-halothane contracture test: a report from the North American Malignant Hyperthermia Registry. The North American Malignant Hyperthermia Registry of MHAUS.","volume":"88","author":"Allen","year":"1998","journal-title":"Anesthesiology"},{"key":"R7-22-20210902","first-page":"103","article-title":"Current diagnostic methods of malignant hyperthermia: an evaluation.","volume":"41","author":"Ording","year":"1990","journal-title":"Acta Anaesthesiol Belg"},{"key":"R8-22-20210902","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1213\/00000539-200008000-00042","article-title":"Between-center variability of results of the in vitro contracture test for malignant hyperthermia susceptibility.","volume":"91","author":"Ording","year":"2000","journal-title":"Anesth Analg"},{"key":"R9-22-20210902","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/343559a0","article-title":"Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia.","volume":"343","author":"MacLennan","year":"1990","journal-title":"Nature"},{"key":"R10-22-20210902","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/343562a0","article-title":"Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-13.2.","volume":"343","author":"McCarthy","year":"1990","journal-title":"Nature"},{"key":"R11-22-20210902","first-page":"12","article-title":"Malignant hyperthermia in New Zealand.","volume":"7","author":"Stowell","year":"1999","journal-title":"NZ BioScience"},{"key":"R13-22-20210902","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/bja\/aer132","article-title":"Malignant hyperthermia: pharmacology of triggering.","volume":"107","author":"Hopkins","year":"2011","journal-title":"Br J Anaesth"},{"key":"R14-22-20210902","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1749-6632.1993.tb38060.x","article-title":"The role of the calcium release channel of skeletal muscle sarcoplasmic reticulum in malignant hyperthermia.","volume":"707","author":"MacLennan","year":"1993","journal-title":"Ann N Y Acad Sci"},{"key":"R15-22-20210902","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1213\/ANE.0b013e3181cbd815","article-title":"Functional properties of RYR1 mutations identified in Swedish patients with malignant hyperthermia and central core disease.","volume":"111","author":"Vukcevic","year":"2010","journal-title":"Anesth Analg"},{"key":"R16-22-20210902","doi-asserted-by":"crossref","first-page":"C1591","DOI":"10.1152\/ajpcell.00133.2006","article-title":"Elevated resting Ca(2)(i) in myotubes expressing malignant hyperthermia RyR1 cDNAs is partially restored by modulation of passive calcium leak from the SR.","volume":"292","author":"Yang","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"R17-22-20210902","doi-asserted-by":"crossref","first-page":"7923","DOI":"10.1073\/pnas.1119207109","article-title":"Malignant hyperthermia susceptibility arising from altered resting coupling between the skeletal muscle L-type Ca2 channel and the type 1 ryanodine receptor.","volume":"109","author":"Eltit","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R18-22-20210902","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1096\/fj.12-218354","article-title":"Nonspecific sarcolemmal cation channels are critical for the pathogenesis of malignant hyperthermia.","volume":"27","author":"Eltit","year":"2013","journal-title":"FASEB J"},{"key":"R19-22-20210902","doi-asserted-by":"crossref","first-page":"25645","DOI":"10.1074\/jbc.M110.104976","article-title":"Store-operated Ca2 entry in malignant hyperthermia-susceptible human skeletal muscle.","volume":"285","author":"Duke","year":"2010","journal-title":"J Biol Chem"},{"key":"R20-22-20210902","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1113\/jphysiol.2009.172148","article-title":"Checking your SOCCs and feet: the molecular mechanisms of Ca2 entry in skeletal muscle.","volume":"587","author":"Dirksen","year":"2009","journal-title":"J Physiol"},{"key":"R21-22-20210902","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/0310057X7700500303","article-title":"Drug treatment of malignant hyperpyrexia.","volume":"5","author":"Austin","year":"1977","journal-title":"Anaesth Intensive Care"},{"key":"R22-22-20210902","doi-asserted-by":"crossref","first-page":"34918","DOI":"10.1074\/jbc.M205487200","article-title":"Identification of a dantrolene-binding sequence on the skeletal muscle ryanodine receptor.","volume":"277","author":"Paul-Pletzer","year":"2002","journal-title":"J Biol Chem"},{"key":"R23-22-20210902","doi-asserted-by":"crossref","first-page":"d671","DOI":"10.2741\/ikemoto","article-title":"Regulation of calcium release by interdomain interaction within ryanodine receptors.","volume":"7","author":"Ikemoto","year":"2002","journal-title":"Front Biosci"},{"key":"R24-22-20210902","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/BF01788371","article-title":"Dihydropyridine receptor-ryanodine receptor interactions in skeletal muscle excitation-contraction coupling.","volume":"15","author":"Meissner","year":"1995","journal-title":"Biosci Rep"},{"key":"R25-22-20210902","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1016\/S0006-3495(02)75325-3","article-title":"Multiple regions of RyR1 mediate functional and structural interactions with alpha(1S)-dihydropyridine receptors in skeletal muscle.","volume":"83","author":"Protasi","year":"2002","journal-title":"Biophys J"},{"key":"R26-22-20210902","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ceca.2004.08.001","article-title":"Intracellular Ca2 dynamics in malignant hyperthermia and central core disease: established concepts, new cellular mechanisms involved.","volume":"37","author":"Avila","year":"2005","journal-title":"Cell Calcium"},{"key":"R27-22-20210902","doi-asserted-by":"crossref","first-page":"23217","DOI":"10.1074\/jbc.M804312200","article-title":"The alpha(1S) III-IV loop influences 1,4-dihydropyridine receptor gating but is not directly involved in excitation-contraction coupling interactions with the type 1 ryanodine receptor.","volume":"283","author":"Bannister","year":"2008","journal-title":"J Biol Chem"},{"key":"R28-22-20210902","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ceca.2010.04.003","article-title":"Skeletal muscle excitation-contraction coupling is independent of a conserved heptad repeat motif in the C-terminus of the DHPRbeta(1a) subunit.","volume":"47","author":"Dayal","year":"2010","journal-title":"Cell Calcium"},{"key":"R29-22-20210902","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1023\/A:1019984714528","article-title":"Calcium regulation and muscle disease.","volume":"23","author":"Gommans","year":"2002","journal-title":"J Muscle Res Cell Motil"},{"key":"R30-22-20210902","first-page":"1479","article-title":"Abnormal uptake and release of Ca2 ions from human malignant hyperthermia-susceptible sarcoplasmic reticulum.","volume":"61","author":"OSullivan","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"R31-22-20210902","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1085\/jgp.119.1.15","article-title":"Interdomain interactions within ryanodine receptors regulate Ca2 spark frequency in skeletal muscle.","volume":"119","author":"Shtifman","year":"2002","journal-title":"J Gen Physiol"},{"key":"R32-22-20210902","doi-asserted-by":"crossref","first-page":"26332","DOI":"10.1074\/jbc.272.42.26332","article-title":"Caffeine and halothane sensitivity of intracellular Ca2 release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia andor central core disease.","volume":"272","author":"Tong","year":"1997","journal-title":"J Biol Chem"},{"key":"R33-22-20210902","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1254\/jjp.88.159","article-title":"Novel mutations in C-terminal channel region of the ryanodine receptor in malignant hyperthermia patients.","volume":"88","author":"Oyamada","year":"2002","journal-title":"Jpn J Pharmacol"},{"key":"R34-22-20210902","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00000542-200308000-00011","article-title":"Detection of a novel ryanodine receptor subtype 1 mutation (R328W) in a malignant hyperthermia family by sequencing of a leukocyte transcript.","volume":"99","author":"Loke","year":"2003","journal-title":"Anesthesiology"},{"issue":"Pt 1","key":"R35-22-20210902","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1042\/bj3340079","article-title":"Expression of ryanodine receptors in human embryonic kidney (HEK293) cells.","volume":"334","author":"Querfurth","year":"1998","journal-title":"Biochem J"},{"key":"R36-22-20210902","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1097\/ALN.0b013e3181d69283","article-title":"Functional studies of RYR1 mutations in the skeletal muscle ryanodine receptor using human RYR1 complementary DNA.","volume":"112","author":"Sato","year":"2010","journal-title":"Anesthesiology"},{"key":"R37-22-20210902","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/ALN.0b013e31828cebfe","article-title":"Skeletal muscle ryanodine receptor mutations associated with malignant hyperthermia showed enhanced intensity and sensitivity to triggering drugs when expressed in human embryonic kidney cells.","volume":"119","author":"Sato","year":"2013","journal-title":"Anesthesiology"},{"key":"R38-22-20210902","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/00000542-200211000-00005","article-title":"Patients with malignant hyperthermia demonstrate an altered calcium control mechanism in B lymphocytes.","volume":"97","author":"Sei","year":"2002","journal-title":"Anesthesiology"},{"key":"R39-22-20210902","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/hmg\/10.25.2879","article-title":"Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: association with central core disease and alteration of calcium homeostasis.","volume":"10","author":"Tilgen","year":"2001","journal-title":"Hum Mol Genet"},{"key":"R40-22-20210902","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/01.anes.0000299431.81267.3e","article-title":"Identification and biochemical characterization of a novel ryanodine receptor gene mutation associated with malignant hyperthermia.","volume":"108","author":"Anderson","year":"2008","journal-title":"Anesthesiology"},{"key":"R41-22-20210902","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1089\/109065703322537214","article-title":"Calcium release from sarcoplasmic reticulum is facilitated in human myotubes derived from carriers of the ryanodine receptor type 1 mutations Ile2182Phe and Gly2375Ala.","volume":"7","author":"Wehner","year":"2003","journal-title":"Genet Test"},{"key":"R42-22-20210902","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1034\/j.1399-0004.2002.620206.x","article-title":"Increased sensitivity to 4-chloro-m-cresol and caffeine in primary myotubes from malignant hyperthermia susceptible individuals carrying the ryanodine receptor 1 Thr2206Met (C6617T) mutation.","volume":"62","author":"Wehner","year":"2002","journal-title":"Clin Genet"},{"key":"R43-22-20210902","doi-asserted-by":"crossref","first-page":"25722","DOI":"10.1074\/jbc.M302165200","article-title":"Functional defects in six ryanodine receptor isoform-1 (RyR1) mutations associated with malignant hyperthermia and their impact on skeletal excitation-contraction coupling.","volume":"278","author":"Yang","year":"2003","journal-title":"J Biol Chem"},{"key":"R44-22-20210902","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1073\/pnas.0812661106","article-title":"A retrograde signal from RyR1 alters DHP receptor inactivation and limits window Ca2 release in muscle fibers of Y522S RyR1 knock-in mice.","volume":"106","author":"Andronache","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R45-22-20210902","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1074\/jbc.M111.307926","article-title":"Gene dose influences cellular and calcium channel dysregulation in heterozygous and homozygous T4826I-RYR1 malignant hyperthermia-susceptible muscle.","volume":"287","author":"Barrientos","year":"2012","journal-title":"J Biol Chem"},{"key":"R46-22-20210902","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1096\/fj.05-4497fje","article-title":"Heat- and anesthesia-induced malignant hyperthermia in an RyR1 knock-in mouse.","volume":"20","author":"Chelu","year":"2006","journal-title":"FASEB J"},{"key":"R47-22-20210902","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1073\/pnas.1115111108","article-title":"Type 1 ryanodine receptor knock-in mutation causing central core disease of skeletal muscle also displays a neuronal phenotype.","volume":"109","author":"De Crescenzo","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R48-22-20210902","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1085\/jgp.200910328","article-title":"A malignant hyperthermia-inducing mutation in RYR1 (R163C): alterations in Ca2 entry, release, and retrograde signaling to the DHPR.","volume":"135","author":"Esteve","year":"2010","journal-title":"J Gen Physiol"},{"key":"R49-22-20210902","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1085\/jgp.201010523","article-title":"Muscle weakness in Ryr1I4895TWT knock-in mice as a result of reduced ryanodine receptor Ca2 ion permeation and release from the sarcoplasmic reticulum.","volume":"137","author":"Loy","year":"2011","journal-title":"J Gen Physiol"},{"key":"R50-22-20210902","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1097\/00000542-200612000-00016","article-title":"Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse.","volume":"105","author":"Yang","year":"2006","journal-title":"Anesthesiology"},{"key":"R51-22-20210902","doi-asserted-by":"crossref","first-page":"11040","DOI":"10.1073\/pnas.0905186106","article-title":"Crystal structure of type I ryanodine receptor amino-terminal beta-trefoil domain reveals a disease-associated mutation hot spot loop.","volume":"106","author":"Amador","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R52-22-20210902","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1007\/s11427-011-4198-2","article-title":"The structural biology of ryanodine receptors.","volume":"54","author":"Kimlicka","year":"2011","journal-title":"Sci China Life Sci"},{"key":"R53-22-20210902","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.str.2009.08.016","article-title":"Crystal structures of the N-terminal domains of cardiac and skeletal muscle ryanodine receptors: insights into disease mutations.","volume":"17","author":"Lobo","year":"2009","journal-title":"Structure"},{"key":"R54-22-20210902","doi-asserted-by":"crossref","first-page":"e38594","DOI":"10.1371\/journal.pone.0038594","article-title":"FRET-based localization of fluorescent protein insertions within the ryanodine receptor type 1.","volume":"7","author":"Raina","year":"2012","journal-title":"PLoS One"},{"key":"R55-22-20210902","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nature09471","article-title":"The amino-terminal disease hotspot of ryanodine receptors forms a cytoplasmic vestibule.","volume":"468","author":"Tung","year":"2010","journal-title":"Nature"},{"key":"R56-22-20210902","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.str.2012.04.015","article-title":"Disease mutations in the ryanodine receptor central region: crystal structures of a phosphorylation hot spot domain.","volume":"20","author":"Yuchi","year":"2012","journal-title":"Structure"},{"key":"R57-22-20210902","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1371\/journal.pbio.1000085","article-title":"Coordinated movement of cytoplasmic and transmembrane domains of RyR1 upon gating.","volume":"7","author":"Samso","year":"2009","journal-title":"PLoS Biol"},{"key":"R58-22-20210902","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jmb.2005.12.023","article-title":"Structural characterization of the RyR1-FKBP12 interaction.","volume":"356","author":"Samso","year":"2006","journal-title":"J Mol Biol"},{"key":"R59-22-20210902","doi-asserted-by":"crossref","first-page":"9610","DOI":"10.1073\/pnas.0803189105","article-title":"Subnanometer-resolution electron cryomicroscopy-based domain models for the cytoplasmic region of skeletal muscle RyR channel.","volume":"105","author":"Serysheva","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R60-22-20210902","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0959-440X(97)80034-6","article-title":"Ryanodine receptors: structure and macromolecular interactions.","volume":"7","author":"Wagenknecht","year":"1997","journal-title":"Curr Opin Struct Biol"},{"key":"R61-22-20210902","doi-asserted-by":"crossref","first-page":"12202","DOI":"10.1074\/jbc.M110.194316","article-title":"Localization of the dantrolene-binding sequence near the FK506-binding protein-binding site in the three-dimensional structure of the ryanodine receptor.","volume":"286","author":"Wang","year":"2011","journal-title":"J Biol Chem"},{"issue":"Pt 3","key":"R62-22-20210902","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1042\/bj3370345","article-title":"Protein-protein interactions in intracellular Ca2-release channel function.","volume":"337","author":"MacKrill","year":"1999","journal-title":"Biochem J"},{"key":"R63-22-20210902","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1242\/jcs.02935","article-title":"The junctional SR protein JP-45 affects the functional expression of the voltage-dependent Ca2 channel Cav1.1.","volume":"119","author":"Anderson","year":"2006","journal-title":"J Cell Sci"},{"key":"R64-22-20210902","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1042\/BJ20070906","article-title":"SRP-27 is a novel component of the supramolecular signalling complex involved in skeletal muscle excitation-contraction coupling.","volume":"411","author":"Bleunven","year":"2008","journal-title":"Biochem J"},{"key":"R65-22-20210902","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1083\/jcb.200404079","article-title":"Junctate is a key element in calcium entry induced by activation of InsP3 receptors andor calcium store depletion.","volume":"166","author":"Treves","year":"2004","journal-title":"J Cell Biol"},{"key":"R66-22-20210902","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1042\/BJ20111457","article-title":"SRP-35, a newly identified protein of the skeletal muscle sarcoplasmic reticulum, is a retinol dehydrogenase.","volume":"441","author":"Treves","year":"2012","journal-title":"Biochem J"},{"key":"R67-22-20210902","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1113\/jphysiol.2009.171876","article-title":"Minor sarcoplasmic reticulum membrane components that modulate excitation-contraction coupling in striated muscles.","volume":"587","author":"Treves","year":"2009","journal-title":"J Physiol"},{"key":"R68-22-20210902","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/humu.22209","article-title":"JP-45JSRP1 variants affect skeletal muscle excitation-contraction coupling by decreasing the sensitivity of the dihydropyridine receptor.","volume":"34","author":"Yasuda","year":"2013","journal-title":"Hum Mutat"},{"key":"R69-22-20210902","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1001\/jama.293.23.2918","article-title":"Malignant hyperthermia: update on susceptibility testing.","volume":"293","author":"Litman","year":"2005","journal-title":"JAMA"},{"key":"R73-22-20210902","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/jmg.35.3.196","article-title":"Genetic heterogeneity and HOMOG analysis in British malignant hyperthermia families.","volume":"35","author":"Robinson","year":"1998","journal-title":"J Med Genet"},{"key":"R74-22-20210902","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1097\/00000542-200405000-00008","article-title":"Molecular genetic testing for malignant hyperthermia susceptibility.","volume":"100","author":"Girard","year":"2004","journal-title":"Anesthesiology"},{"key":"R75-22-20210902","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D","article-title":"Ryanodine receptor mutations in malignant hyperthermia and central core disease.","volume":"15","author":"McCarthy","year":"2000","journal-title":"Hum Mutat"},{"key":"R76-22-20210902","first-page":"189","article-title":"The role of the skeletal muscle ryanodine receptor gene in malignant hyperthermia.","volume":"46","author":"MacLennan","year":"1992","journal-title":"Symp Soc Exp Biol"},{"key":"R77-22-20210902","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/humu.20356","article-title":"Mutations in RYR1 in malignant hyperthermia and central core disease.","volume":"27","author":"Robinson","year":"2006","journal-title":"Hum Mutat"},{"key":"R78-22-20210902","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/(SICI)1097-4598(200001)23:1<4::AID-MUS3>3.0.CO;2-D","article-title":"Genetics and pathogenesis of malignant hyperthermia.","volume":"23","author":"Jurkat-Rott","year":"2000","journal-title":"Muscle Nerve"},{"key":"R79-22-20210902","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1086\/515454","article-title":"Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle.","volume":"60","author":"Monnier","year":"1997","journal-title":"Am J Hum Genet"},{"key":"R80-22-20210902","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s12630-010-9314-4","article-title":"A report of fulminant malignant hyperthermia in a patient with a novel mutation of the CACNA1S gene.","volume":"57","author":"Toppin","year":"2010","journal-title":"Can J Anaesth"},{"key":"R81-22-20210902","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1471-2350-10-104","article-title":"The role of CACNA1S in predisposition to malignant hyperthermia.","volume":"10","author":"Carpenter","year":"2009","journal-title":"BMC Med Genet"},{"key":"R82-22-20210902","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/ALN.0b013e3181c29504","article-title":"Exertional rhabdomyolysis and malignant hyperthermia in a patient with ryanodine receptor type 1 gene, L-type calcium channel alpha-1 subunit gene, and calsequestrin-1 gene polymorphisms.","volume":"112","author":"Capacchione","year":"2010","journal-title":"Anesthesiology"},{"key":"R83-22-20210902","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1113\/jphysiol.2009.171967","article-title":"Calsequestrin-1: a new candidate gene for malignant hyperthermia and exertionalenvironmental heat stroke.","volume":"587","author":"Protasi","year":"2009","journal-title":"J Physiol"},{"key":"R84-22-20210902","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/01.anes.0000530185.78660.da","article-title":"CASQ1 gene is an unlikely candidate for malignant hyperthermia susceptibility in the North American population.","volume":"118","author":"Kraeva","year":"2013","journal-title":"Anesthesiology"},{"key":"R85-22-20210902","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00439-002-0864-6","article-title":"Several interacting genes influence the malignant hyperthermia phenotype.","volume":"112","author":"Robinson","year":"2003","journal-title":"Hum Genet"},{"key":"R86-22-20210902","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/hmg\/9.10.1515","article-title":"A novel ryanodine receptor mutation and genotype-phenotype correlation in a large malignant hyperthermia New Zealand Maori pedigree.","volume":"9","author":"Brown","year":"2000","journal-title":"Hum Mol Genet"},{"key":"R87-22-20210902","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00000542-200211000-00007","article-title":"Presence of two different genetic traits in malignant hyperthermia families: implication for genetic analysis, diagnosis, and incidence of malignant hyperthermia susceptibility.","volume":"97","author":"Monnier","year":"2002","journal-title":"Anesthesiology"},{"key":"R88-22-20210902","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1093\/hmg\/ddl221","article-title":"Characterization of recessive RYR1 mutations in core myopathies.","volume":"15","author":"Zhou","year":"2006","journal-title":"Hum Mol Genet"},{"key":"R89-22-20210902","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1213\/ANE.0b013e31824a95ad","article-title":"Novel double and single ryanodine receptor 1 variants in two Austrian malignant hyperthermia families.","volume":"114","author":"Kaufmann","year":"2012","journal-title":"Anesth Analg"},{"key":"R91-22-20210902","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1172-2-21","article-title":"Malignant hyperthermia.","volume":"2","author":"Rosenberg","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"R92-22-20210902","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ceca.2008.11.005","article-title":"Alternative splicing of RyR1 alters the efficacy of skeletal EC coupling.","volume":"45","author":"Kimura","year":"2009","journal-title":"Cell Calcium"},{"key":"R93-22-20210902","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1086\/508500","article-title":"Epigenetic allele silencing unveils recessive RYR1 mutations in core myopathies.","volume":"79","author":"Zhou","year":"2006","journal-title":"Am J Hum Genet"},{"key":"R94-22-20210902","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/humu.9442","article-title":"Frequency and localization of mutations in the 106 exons of the RYR1 gene in 50 individuals with malignant hyperthermia.","volume":"27","author":"Galli","year":"2006","journal-title":"Hum Mutat"},{"key":"R95-22-20210902","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1177\/0310057X0803600311","article-title":"Identification of genetic mutations in Australian malignant hyperthermia families using sequencing of RYR1 hotspots.","volume":"36","author":"Gillies","year":"2008","journal-title":"Anaesth Intensive Care"},{"key":"R96-22-20210902","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00000542-200503000-00007","article-title":"Screening of the entire ryanodine receptor type 1 coding region for sequence variants associated with malignant hyperthermia susceptibility in the north american population.","volume":"102","author":"Sambuughin","year":"2005","journal-title":"Anesthesiology"},{"key":"R97-22-20210902","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1213\/ANE.0b013e318228293e","article-title":"Screening of the ryanodine 1 gene for malignant hyperthermia causative mutations by high resolution melt curve analysis.","volume":"113","author":"Broman","year":"2011","journal-title":"Anesth Analg"},{"key":"R98-22-20210902","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1213\/ANE.0b013e31828a71ff","article-title":"Ryanodine receptor type 1 gene variants in the malignant hyperthermia-susceptible population of the United States.","volume":"116","author":"Brandom","year":"2013","journal-title":"Anesth Analg"},{"key":"R99-22-20210902","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1399-0004.2009.01251.x","article-title":"The ryanodine receptor type 1 gene variants in African American men with exertional rhabdomyolysis and malignant hyperthermia susceptibility.","volume":"76","author":"Sambuughin","year":"2009","journal-title":"Clin Genet"},{"key":"R100-22-20210902","first-page":"43","article-title":"Detection of single nucleotide polymorphisms.","volume":"5","author":"Kwok","year":"2003","journal-title":"Curr Issues Mol Biol"},{"key":"R101-22-20210902","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1373\/clinchem.2004.045336","article-title":"Fifty years of molecular (DNARNA) diagnostics.","volume":"51","author":"Gingeras","year":"2005","journal-title":"Clin Chem"},{"key":"R102-22-20210902","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1073\/pnas.74.12.5463","article-title":"DNA sequencing with chain-terminating inhibitors.","volume":"74","author":"Sanger","year":"1977","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R103-22-20210902","first-page":"71","article-title":"SNP discovery by direct DNA sequencing.","volume":"212","author":"Kwok","year":"2003","journal-title":"Methods Mol Biol"},{"key":"R104-22-20210902","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/humu.20878","article-title":"Increasing the number of diagnostic mutations in malignant hyperthermia.","volume":"30","author":"Levano","year":"2009","journal-title":"Hum Mutat"},{"key":"R106-22-20210902","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/00000542-200410000-00005","article-title":"Malignant hyperthermia in North America: genetic screening of the three hot spots in the type I ryanodine receptor gene.","volume":"101","author":"Sei","year":"2004","journal-title":"Anesthesiology"},{"key":"R107-22-20210902","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/bja\/aep204","article-title":"Genetic variation in RYR1 and malignant hyperthermia phenotypes.","volume":"103","author":"Carpenter","year":"2009","journal-title":"Br J Anaesth"},{"key":"R108-22-20210902","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/bja\/aes341","article-title":"Sequence capture and massively parallel sequencing to detect mutations associated with malignant hyperthermia.","volume":"110","author":"Schiemann","year":"2013","journal-title":"Br J Anaesth"},{"key":"R110-22-20210902","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1042\/BJ20051282","article-title":"Functional properties of ryanodine receptors carrying three amino acid substitutions identified in patients affected by multi-minicore disease and central core disease, expressed in immortalized lymphocytes.","volume":"395","author":"Ducreux","year":"2006","journal-title":"Biochem J"},{"key":"R111-22-20210902","doi-asserted-by":"crossref","first-page":"43838","DOI":"10.1074\/jbc.M403612200","article-title":"Effect of ryanodine receptor mutations on interleukin-6 release and intracellular calcium homeostasis in human myotubes from malignant hyperthermia-susceptible individuals and patients affected by central core disease.","volume":"279","author":"Ducreux","year":"2004","journal-title":"J Biol Chem"},{"key":"R112-22-20210902","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.nmd.2012.08.007","article-title":"Novel excitation-contraction uncoupled RYR1 mutations in patients with central core disease.","volume":"23","author":"Kraeva","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"R113-22-20210902","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.nmd.2004.03.011","article-title":"Functional characterization of malignant hyperthermia-associated RyR1 mutations in exon 44, using the human myotube model.","volume":"14","author":"Wehner","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"R114-22-20210902","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/hmg\/ddg032","article-title":"Clinical and functional effects of a deletion in a COOH-terminal lumenal loop of the skeletal muscle ryanodine receptor.","volume":"12","author":"Zorzato","year":"2003","journal-title":"Hum Mol Genet"},{"key":"R115-22-20210902","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1085\/jgp.118.3.277","article-title":"Functional effects of central core disease mutations in the cytoplasmic region of the skeletal muscle ryanodine receptor.","volume":"118","author":"Avila","year":"2001","journal-title":"J Gen Physiol"},{"key":"R116-22-20210902","doi-asserted-by":"crossref","first-page":"15380","DOI":"10.1074\/jbc.M410421200","article-title":"Ca2 signaling in HEK-293 and skeletal muscle cells expressing recombinant ryanodine receptors harboring malignant hyperthermia and central core disease mutations.","volume":"280","author":"Brini","year":"2005","journal-title":"J Biol Chem"},{"key":"R117-22-20210902","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00540-009-0746-3","article-title":"Functional analysis of ryanodine receptor type 1 p.R2508C mutation in exon 47.","volume":"23","author":"Migita","year":"2009","journal-title":"J Anesth"},{"key":"R118-22-20210902","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/346569a0","article-title":"Intramembrane charge movement restored in dysgenic skeletal muscle by injection of dihydropyridine receptor cDNAs.","volume":"346","author":"Adams","year":"1990","journal-title":"Nature"},{"key":"R119-22-20210902","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1085\/jgp.200810105","article-title":"The skeletal L-type Ca(2) current is a major contributor to excitation-coupled Ca(2) entry.","volume":"133","author":"Bannister","year":"2009","journal-title":"J Gen Physiol"},{"key":"R120-22-20210902","doi-asserted-by":"crossref","first-page":"C1094","DOI":"10.1152\/ajpcell.00173.2004","article-title":"Functional analysis of the R1086H malignant hyperthermia mutation in the DHPR reveals an unexpected influence of the III-IV loop on skeletal muscle EC coupling.","volume":"287","author":"Weiss","year":"2004","journal-title":"Am J Physiol Cell Physiol"},{"key":"R121-22-20210902","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1529\/biophysj.104.048447","article-title":"Distinct effects on Ca2 handling caused by malignant hyperthermia and central core disease mutations in RyR1.","volume":"87","author":"Dirksen","year":"2004","journal-title":"Biophys J"},{"key":"R122-22-20210902","doi-asserted-by":"crossref","first-page":"e54042","DOI":"10.1371\/journal.pone.0054042","article-title":"Ca2 release in muscle fibers expressing R4892W and G4896V type 1 ryanodine receptor disease mutants.","volume":"8","author":"Lefebvre","year":"2013","journal-title":"PLoS One"},{"key":"R123-22-20210902","doi-asserted-by":"crossref","first-page":"C179","DOI":"10.1152\/ajpcell.00176.2003","article-title":"Conformational coupling of DHPR and RyR1 in skeletal myotubes is influenced by long-range allosterism: evidence for a negative regulatory module.","volume":"286","author":"Lee","year":"2004","journal-title":"Am J Physiol Cell Physiol"},{"key":"R125-22-20210902","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1469-1809.2000.6440307.x","article-title":"Multiple interacting gene products may influence susceptibility to malignant hyperthermia.","volume":"64","author":"Robinson","year":"2000","journal-title":"Ann Hum Genet"},{"key":"R126-22-20210902","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1756-0381-6-13","article-title":"Unraveling genomic variation from next generation sequencing data.","volume":"6","author":"Pavlopoulos","year":"2013","journal-title":"BioData Min"},{"key":"R127-22-20210902","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nrg2986","article-title":"Genotype and SNP calling from next-generation sequencing data.","volume":"12","author":"Nielsen","year":"2011","journal-title":"Nat Rev Genet"},{"key":"R128-22-20210902","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nrg3046","article-title":"Needles in stacks of needles: finding disease-causal variants in a wealth of genomic data.","volume":"12","author":"Cooper","year":"2011","journal-title":"Nat Rev Genet"},{"key":"R130-22-20210902","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/nbt.1975","article-title":"Performance comparison of exome DNA sequencing technologies.","volume":"29","author":"Clark","year":"2011","journal-title":"Nat Biotechnol"},{"key":"R131-22-20210902","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nbt.2065","article-title":"Performance comparison of whole-genome sequencing platforms.","volume":"30","author":"Lam","year":"2012","journal-title":"Nat Biotechnol"},{"key":"R132-22-20210902","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrg2626","article-title":"Sequencing technologies-the next generation.","volume":"11","author":"Metzker","year":"2010","journal-title":"Nat Rev Genet"},{"key":"R133-22-20210902","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ng.806","article-title":"A framework for variation discovery and genotyping using next-generation DNA sequencing data.","volume":"43","author":"DePristo","year":"2011","journal-title":"Nat Genet"},{"issue":"Suppl 7","key":"R134-22-20210902","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1186\/1471-2105-14-S7-S11","article-title":"WEP: a high-performance analysis pipeline for whole-exome data.","volume":"14","author":"DAntonio","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"R135-22-20210902","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nrg3433","article-title":"Computational solutions for omics data.","volume":"14","author":"Berger","year":"2013","journal-title":"Nat Rev Genet"},{"key":"R136-22-20210902","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/humu.21428","article-title":"Massive parallel amplicon sequencing of the breast cancer genes BRCA1 and BRCA2: opportunities, challenges, and limitations.","volume":"32","author":"De Leeneer","year":"2011","journal-title":"Hum Mutat"},{"key":"R137-22-20210902","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/tan.12071","article-title":"High throughput HLA genotyping using 454 sequencing and the Fluidigm Access Array System for simplified amplicon library preparation.","volume":"81","author":"Moonsamy","year":"2013","journal-title":"Tissue Antigens"},{"key":"R138-22-20210902","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/1471-2164-11-252","article-title":"Haplotyping and copy number estimation of the highly polymorphic human beta-defensin locus on 8p23 by 454 amplicon sequencing.","volume":"11","author":"Taudien","year":"2010","journal-title":"BMC Genomics"},{"key":"R139-22-20210902","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1093\/nar\/gkm760","article-title":"A pyrosequencing-tailored nucleotide barcode design unveils opportunities for large-scale sample multiplexing.","volume":"35","author":"Parameswaran","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"R140-22-20210902","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nmeth1109","article-title":"Microarray-based genomic selection for high-throughput resequencing.","volume":"4","author":"Okou","year":"2007","journal-title":"Nat Methods"},{"key":"R141-22-20210902","doi-asserted-by":"crossref","first-page":"R94","DOI":"10.1186\/gb-2011-12-9-r94","article-title":"Comparison of solution-based exome capture methods for next generation sequencing.","volume":"12","author":"Sulonen","year":"2011","journal-title":"Genome Biol"},{"key":"R142-22-20210902","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/bja\/aes341","article-title":"Sequence capture and massively parallel sequencing to detect mutations associated with malignant hyperthermia.","volume":"110","author":"Scheimann","year":"2013","journal-title":"Br J Anaesth"},{"key":"R143-22-20210902","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/978-1-61779-848-1_24","article-title":"Exome sequencing: capture and sequencing of all human coding regions for disease gene discovery.","volume":"884","author":"Priya","year":"2012","journal-title":"Methods Mol Biol"},{"key":"R145-22-20210902","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/ALN.0b013e3182a8a998","article-title":"Exome sequencing reveals novel rare variants in the ryanodine receptor and calcium channel genes in malignant hyperthermia families.","volume":"119","author":"Kim","year":"2013","journal-title":"Anesthesiology"},{"key":"R146-22-20210902","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-1-62703-514-9_8","article-title":"Exome sequencing analysis: a guide to disease variant detection.","volume":"1038","author":"Isakov","year":"2013","journal-title":"Methods Mol Biol"},{"key":"R147-22-20210902","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/nrg2795","article-title":"Next-generation genomics: an integrative approach.","volume":"11","author":"Hawkins","year":"2010","journal-title":"Nat Rev Genet"},{"key":"R148-22-20210902","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2478\/v10034-012-0018-7","article-title":"Integrative omic approach towards understanding the nature of human diseases.","volume":"15","author":"Peterlin","year":"2012","journal-title":"Balkan J Med Genet"},{"key":"R149-22-20210902","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/gim.2013.113","article-title":"Recommendations for returning genomic incidental findings We need to talk!","volume":"15","author":"Burke","year":"2013","journal-title":"Genet Med"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000000063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:22:16Z","timestamp":1786112536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201402000-00022"}},"subtitle":["The Reality and the Dream"],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":138,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000000063","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}